Facilitated temporal summation of pain at spinal level in Parkinson's disease

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 442-448

  Perrotta, Armando ^a,b   Sandrini, Giorgio ^a   Serrao, Mariano ^b,c   Buscone, Simona ^a   Tassorelli, Cristina ^a   Tinazzi, Michele ^d   Zangaglia, Roberta ^a   Pacchetti, Claudio ^a   Bartolo, Michelangelo ^a,b   Pierelli, Francesco ^b   Martignoni, Emilia ^e  

^a UNIVERSITY OF PAVIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Nociceptive withdrawal reflex; Pain; Parkinson's disease; Temporal summation

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NOCICEPTION; OUTCOME ASSESSMENT; PAIN THRESHOLD; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINAL PAIN; TEMPORAL SUMMATION; TREATMENT FAILURE; WITHDRAWAL REFLEX;

ADULT; AGED; ANTIPARKINSON AGENTS; DISABILITY EVALUATION; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PARKINSON DISEASE; PHYSICAL STIMULATION; PSYCHOPHYSICS; REFLEX; SEVERITY OF ILLNESS INDEX; SPINAL CORD;

EID: 79953287880     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23458     Document Type: Article

References (50)

1. Ford B. Pain in Parkinson's disease. Clin Neurosci 1998; 5: 63-72.
2. Wasner G, Deuschl G. Chapter 50 pain in Parkinson's disease. Handb Clin Neurol 2006; 81: 747-760.
3. Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 2008; 65: 1191-1194.
4. Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinson's disease: prevalence and characteristics. Pain 2009; 141: 173-177.
5. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 822-825.
6. Djaldetti R, Shifrin AMD, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171-2175.
7. Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2005; 20: 1557-1563.
8. Perrotta A, Serrao M, Bartolo M, et al. Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease. Clin Neurophysiol 2005; 116: 2091-2098.
9. Schestatsky P, Kumru H, Valls-Solé J, et al. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 2007; 69: 2162-2169.
10. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 2007; 78: 1140-1142.
11. Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 24-28.
12. 2 laser evoked potentials. Pain 2008; 136: 117-124.
13. Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain 1995; 60: 3-38.
14. Lindvall O, Björklund A, Skagerberg G. Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol 1983; 14: 255-260.
15. Potvin S, Grignon S, Marchand S. Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse 2009; 62: 390-402.
16. Pertovaara A, Wei H. Dual influence of the striatum on neuropathic hypersensitivity. Pain 2008; 137: 50-59.
17. Tassorelli C, Armentero MT, Greco R, et al. Behavioural responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease. Brain Res 2007; 1176: 53-61.
18. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10: 895-926.
19. Woolf CJ. Central sensitization: uncovering the relation between pain and plasticity. Anesthesiology 2007; 106: 864-867.
20. Eide PK. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain 2000; 4: 5-15.
21. Mendell LM. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 1966; 16: 316-332.
22. Herrero JF, Laird JM, Lopez-Garcia JA. Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol 2000; 61: 169-203.
23. You HJ, Dahl Morch C, Chen J, Arendt-Nielsen L. Simultaneous recordings of wind-up of paired spinal dorsal horn nociceptive neuron and nociceptive flexion reflex in rats. Brain Res 2003; 960: 235-245.
24. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91: 165-175.
25. Weissman-Fogel I, Sprecher E, Granovsky Y, Yarnitsky D. Repeated noxious stimulation of the skin enhances cutaneous pain perception of migraine patients in-between attacks: clinical evidence for continuous sub-threshold increase in membrane excitability of central trigeminovascular neurons. Pain 2003; 104: 693-700.
26. Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R. Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 2006; 26: 940-948.
27. Perrotta A, Serrao M, Sandrini, et al. Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia (in press).
28. Arendt-Nielsen L, Brennum J, Sindrup S, Bak P. Electrophysiological and psychophysical quantification of temporal summation in the human nociceptive system. Eur Appl Physiol Occup Physiol 1994; 68: 266-273.
29. Banic B, Petersen-Felix S, Andersen OK, et al. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 2004; 107: 7-15.
30. Sandrini G, Serrao M, Rossi P, Romaniello A, Cruccu G, Willer JC. The lower limb flexion reflex in humans. Prog Neurobiol 2005; 77: 353-395.
31. Serrao M, Rossi P, Sandrini G, et al. Effects of diffuse noxious inhibitory controls on temporal summation of the NWR reflex in humans. Pain 2004; 112: 353-360.
32. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
33. Hughes AJ, Daniel SE, Kliford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
34. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
35. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Mardsen CD, Calne D, editors. Recent developments in Parkinson's disease. New Jersey: Macmillan Healthcare Information; 1987. p 153-613.
36. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-172.
37. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain 1999; 81: 147-154.
38. Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004; 11: 153-162.
39. Merksey H, Bogduk N, editors. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press; 1994. p 209-212.
40. Andersen OK, Felsby S, Nicolaisen L, Bjerring P, Jensen TS, Arendt-Nielsen L. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin--a double-blind, placebo-controlled, human experimental study. Pain 1996; 66: 51-62.
41. Staud R, Robinson ME, Vierck CJ Jr, Price DD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003; 101: 167-174.
42. Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 2005; 118: 215-223.
43. Sandrini G, Rossi P, Milanov I, Serrao M, Cecchini A, Nappi G. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia 2006; 26: 782-789.
44. Tinazzi M, Recchia S, Simonetto S, et al. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing. J Neurol Sci 2009; 276: 153-158.
45. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999; 96: 7687-7692.
46. Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007; 113: 421-429.
47. Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66: 355-474.
48. Porreca F, Ossipoy MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002; 25: 319-325.
49. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
50. Braak H, Rüb U, Sandmann-Keil D, et al. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol 2000; 99: 489-495.